A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle
about
Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptorEffects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal functionFunctional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle responseCorticotropin-releasing factor receptor 2 is a tonic suppressor of vascularizationCorticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neuronsA single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonistsGlucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent isletsA novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart diseaseIs it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health.Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.Altered maternal profiles in corticotropin-releasing factor receptor 1 deficient miceStructural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activityExpression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor.Modulation of Sleep Homeostasis by Corticotropin Releasing Hormone in REM Sleep-Deprived RatsDifferentiation and regulation of the corticotropic pituitary cell.CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells.Anorexia nervosa: a unified neurological perspectiveUrocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying.Expression of urocortin peptides in canine myocardium and plasmaKey role of CRF in the skin stress response system.Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis.Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscleChemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems.The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stressEffects of voluntary running in the female mice lateral septum on BDNF and corticotropin-releasing factor receptor 2Peripheral corticotropin-releasing factor receptor type 2 activation increases colonic blood flow through nitric oxide pathway in ratsUrocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stressDistribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular systemMapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle.cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regenerationUrocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders.Regulation of gonadotropins by corticotropin-releasing factor and urocortin
P2860
Q24314090-6D9E727E-C1DF-41AF-A1E8-1900530A06D3Q24629375-4B6A635D-5CC1-4D82-B66E-B0AB7CEA7CD3Q28144958-C21D0BBD-35E8-43A1-9095-26556B52C016Q28359804-CC7EB01D-E84E-4111-974A-1D3073C2938AQ28507210-DF237F25-060B-46F6-97A0-84B30FB52D3FQ28511231-B7E09F4C-D7CD-4631-BD5A-920D4A806667Q28568495-0EE0FDF2-519A-4C55-8CF4-6D794441FCF5Q28572089-3F29AFB9-5A21-4EEA-B4DA-E616E3C684D7Q28579641-0B67257D-F96E-4221-B04A-E3008C7B6309Q28588519-24AB11EC-BC61-4310-8A81-CD70C861C5CBQ30457438-AA1FF5D7-0A29-4B0C-8147-3677FC5ACCD0Q30487401-B01D29AB-DFE7-4696-9A03-5F486B9C7ABFQ30502566-823B47AD-011C-457E-8BCE-EBF1CA06B21FQ33276252-3DC15693-FCDB-4097-9693-5ABE737E02D0Q33577261-BF143DA0-4CF0-4026-A2C8-EBD6BE0EEF4BQ33785575-0E1267F7-FCBF-4397-B315-AA7AA78E0742Q33850519-511B7033-844E-4798-8D5D-22B309C9674CQ33953071-73137B41-5AF1-48B7-9229-580A8BA78181Q33984742-C59E0C52-BB3E-4BA0-92E1-A6CEF9A9FC04Q34203993-86776ADC-EC7B-4B04-999A-4113E1CCB60BQ34223469-32B04842-6F42-4C9F-9E88-38C989A1BC64Q34237631-904C35B9-618A-496C-9BD2-864445F6714DQ34240005-AF89203A-29EC-4B6E-9E8A-A9D9D9A9518BQ34316461-578BC807-BC20-40E0-B507-85EA2B5F8C79Q34363640-5A77F0A7-3CE7-414E-9AA6-7870EB943279Q34471162-400DE24C-8B48-4503-8FAE-E64792A1079BQ34480384-7790550E-15B5-406E-B715-03F42847828AQ35133923-84FD0187-5FF8-4A45-AC6E-B14BA1D7287AQ35148867-001B20D3-EF9A-4A3A-B795-8CE30131FA52Q35236877-52F5EF2E-BEFB-48B1-9784-104F19EAFB8AQ35250973-DBC568A9-EAA8-4614-BA1A-FF333D35FA80Q35564811-CC845124-4402-46F6-B139-7D94C94A8A70Q35945103-39109F8D-389C-4D23-BA33-10D070B84712Q35996841-E6148ADA-F560-4BFB-A0FC-BA4CE6997DB4Q36060471-B810268F-8D10-4DB8-A6A9-2D5E3A45D204Q36073670-C9543C2B-DFF2-401F-96AD-9E51A46682DBQ36114861-68478909-563D-495B-A360-DD9CE4B133A0Q36207802-20013BE2-7463-4C68-84DE-53ED11444137Q36219686-CEA06189-64E1-401F-A5A3-A3E6BC67F625Q36622194-E34B6CFA-CDE9-42DD-BDC6-ADFA1539314C
P2860
A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@ast
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@en
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@nl
type
label
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@ast
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@en
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@nl
prefLabel
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@ast
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@en
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@nl
P2093
P2860
P356
P1476
A sauvagine/corticotropin-rele ...... d in heart and skeletal muscle
@en
P2093
M G Rosenfeld
R V Pearse
T Kishimoto
P2860
P304
P356
10.1073/PNAS.92.4.1108
P407
P577
1995-02-01T00:00:00Z